IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.2010
+0.0150 (8.06%)
Aug 3, 2026, 12:06 PM CET
IntegraGen Market Cap
IntegraGen has a market cap or net worth of €1.23 million as of August 3, 2026. Its market cap has decreased by -34.99% in one year.
Market Cap
1.23M
Enterprise Value
416.00K
Revenue
5.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.20
ChartMarket Cap Chart
Since June 18, 2010, IntegraGen's market cap has decreased from 34.24M to 1.23M, a decrease of -96.42%. That is a compound annual growth rate of -18.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.23M | 39.30% |
| Dec 31, 2025 | 880.55K | -76.46% |
| Dec 31, 2024 | 3.74M | -36.97% |
| Dec 29, 2023 | 5.93M | -25.72% |
| Dec 30, 2022 | 7.99M | 8.73% |
| Dec 31, 2021 | 7.35M | -46.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |
| Poxel | 11.26M |
| NFL Biosciences | 11.02M |
| Aton | 8.45M |
| Oncodesign Precision Medicine Société anonyme | 6.13M |
| TME Pharma | 5.89M |
| Plant Advanced Technologies | 5.49M |